13F-HR filed by Yorkville Advisors Global, LP
Yorkville Advisors Global, LP filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-11-21, with 22 holding rows worth $345,973,397.
- Accession
- 0001104659-25-114981
- Filer
- CIK 1838613
- Filed
- 2025-11-21
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2025
A holdings report, 22 entries on the cover page, a total value of $345,973,397 stated on the cover page (in dollars after the unit check, H1), rows summing to $345,973,397 with VALUE read as dollars as filed, 13F file number 028-25882. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TRUMP MEDIA & TECHNOLOGY | 25400Q105 | COM | 9,700,862 | $175,003,550 | dollars as filed | |
| Sequans Communications SA | 817323306 | SPONSORED ADS | 10,227,115 | $150,338,591 | dollars as filed | |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 22,000,000 | $11,908,600 | dollars as filed | |
| MURANO GLOBAL INVT PLC | G63369105 | SHS | 253,070 | $2,669,888 | dollars as filed | |
| LUMINAR TECHNOLOGIES INC | 550424303 | COM NEW CL A | 405,926 | $1,165,008 | dollars as filed | |
| NUBURU INC | 67021W301 | COM NEW | 2,665,246 | $931,770 | dollars as filed | |
| FIBROBIOLOGICS INC | 31573L105 | COM SHS | 844,103 | $525,201 | dollars as filed | |
| TRILLER GROUP INC | 895970101 | COM | 480,426 | $447,036 | dollars as filed | |
| APIMEDS PHARMACEUTICALS US I | 03771D102 | COM SHS | 250,000 | $440,000 | dollars as filed | |
| COEPTIS THERAPEUTICS HLDGS I | 19207A207 | COM NEW | 52,724 | $411,247 | dollars as filed | |
| CELULARITY INC | 151190204 | CL A NEW | 200,000 | $392,000 | dollars as filed | |
| N2OFF INC | 80512Q402 | COM | 1,505,675 | $346,305 | dollars as filed | |
| MSP Recovery, Inc | 553745308 | CL A | 230,000 | $319,700 | dollars as filed | |
| MEDICUS PHARMA LTD | 58471K202 | COM | 105,840 | $316,462 | dollars as filed | |
| ENVIROTECH VEHICLES INC | 29414V209 | COM NEW | 1,250,000 | $223,750 | dollars as filed | |
| REZOLVE AI PLC | G75398900 | CALL | 2,000 | $182,000 | dollars as filed | call |
| NEUROSENSE THERAPEUTICS LTD | M74240108 | FOREIGN | 60,000 | $113,400 | dollars as filed | |
| SCINAI IMMUNOTHERAPEUTICS LT | 09073Q303 | SPONSORED ADR | 42,000 | $95,760 | dollars as filed | |
| TRUMP MEDIA & TECHNOLOGY GRO | 25400Q955 | COM | 11,641,500 | $49,750 | dollars as filed | put |
| FORESIGHT AUTONOMOUS HLDGS L | 345523203 | SPONSORED ADR | 100,000 | $46,500 | dollars as filed | |
| X3 HOLDINGS CO LTD | G72007134 | COM | 17,831 | $28,709 | dollars as filed | |
| ESHALLGO INC | G3121H103 | USD ORD SHS CL A | 23,000 | $18,170 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-25-114981 | this filing | 2025-11-21 | acceptance time not in the bulk data set |